SGCB and Cirrhosis: Two experimental studies investigated the effects of the sGC activator BAY 60–2770 in experimental cirrhosis: Knorr et al. demonstrated first, that BAY 60–2770 exhibits antifibrotic effects in rat models of CCl4-fibrosis and pig-serum induced liver injury23.